Vivian Y. Liao

Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Add-on treatment with vinpocetine reduces seizure frequency and improves comorbidities in patients with loss-of-function γ-aminobutyric acid type A receptor variants.

Add-on treatment with vinpocetine reduces seizure frequency and improves comorbidities in patients with loss-of-function γ-aminobutyric acid type A receptor variants.

Journal: Epilepsia

Published: February 03, 2026

Accurate prediction of gain- and loss-of-function missense variants in GABAA receptors.

Accurate prediction of gain- and loss-of-function missense variants in GABAA receptors.

Journal: EBioMedicine

Published: January 05, 2026

Phenotypic Spectrum in Individuals With Pathogenic GABRG2 Loss- and Gain-of-Function Variants.

Phenotypic Spectrum in Individuals With Pathogenic GABRG2 Loss- and Gain-of-Function Variants.

Journal: Neurology

Published: June 26, 2025

Understanding paralogous epilepsy-associated GABAA receptor variants: Clinical implications, mechanisms, and potential pitfalls.

Understanding paralogous epilepsy-associated GABAA receptor variants: Clinical implications, mechanisms, and potential pitfalls.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: December 06, 2024

GABAA receptors in epilepsy: Elucidating phenotypic divergence through functional analysis of genetic variants.

GABAA receptors in epilepsy: Elucidating phenotypic divergence through functional analysis of genetic variants.

Journal: Journal of neurochemistry

Published: May 21, 2023

Vinpocetine improved neuropsychiatric and epileptic outcomes in a patient with a GABRA1 loss-of-function variant.

Vinpocetine improved neuropsychiatric and epileptic outcomes in a patient with a GABRA1 loss-of-function variant.

Journal: Annals of clinical and translational neurology

Published: December 31, 2022

Correlations of receptor desensitization of gain-of-function GABRB3 variants with clinical severity.

Correlations of receptor desensitization of gain-of-function GABRB3 variants with clinical severity.

Journal: Brain : a journal of neurology

Published: December 28, 2022

GABRA1-Related Disorders: From Genetic to Functional Pathways.

GABRA1-Related Disorders: From Genetic to Functional Pathways.

Journal: Annals of neurology

Published: December 08, 2022

3,5-bis(styryl)pyrazole inhibits mitosis and induces cell death independent of BubR1 and p53 levels by depolymerizing microtubules.

3,5-bis(styryl)pyrazole inhibits mitosis and induces cell death independent of BubR1 and p53 levels by depolymerizing microtubules.

Journal: Journal of biochemistry

Published: November 23, 2022

The de novo GABRA4 p.Thr300Ile variant found in a patient with early-onset intractable epilepsy and neurodevelopmental abnormalities displays gain-of-function traits.

The de novo GABRA4 p.Thr300Ile variant found in a patient with early-onset intractable epilepsy and neurodevelopmental abnormalities displays gain-of-function traits.

Journal: Epilepsia

Published: May 06, 2022

Gain-of-function and loss-of-function GABRB3 variants lead to distinct clinical phenotypes in patients with developmental and epileptic encephalopathies.

Gain-of-function and loss-of-function GABRB3 variants lead to distinct clinical phenotypes in patients with developmental and epileptic encephalopathies.

Journal: Nature communications

Published: October 01, 2021

Structural mapping of GABRB3 variants reveals genotype-phenotype correlations.

Structural mapping of GABRB3 variants reveals genotype-phenotype correlations.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: September 30, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026